新环境新机遇威高国际化战略经验分享--威高集团 陈敏.pdf

1、Leading supplier of medical devices,products and integrated solutions in the PRC新 环 境、新 机 遇，New environment,new opportunities,Y O U R H E A L T H W E C A R E威高集团威高国际化战略经验分享WEGOs internationalization strategyWEGO Overiew威高概述中国企业500强；2022年实现营收515亿元。PAT E N T SF D AN M PACE ATI PRODUCTSTop 500 Chinese

2、enterprises，Revenue:51.5 billion in 2022($7.5billion)专 利 数 量FDA注册国内注册证数量C E 认 证国际先进技术产品2027年，威高30%的产品将由新材料、新技术、新工艺实现品质提升，50%的营收将由创新性高值医疗器械贡献。In 2027,30%products will be improved by new materials,new technologies and new processes,50%of sales will be contributed by high-value medical devices innovati

3、onGermany德国研发中心Japan日本研发中心销售覆盖100国家和地区100多家子公司 3家上市公司 8家海外公司 中国10个省市建有制造基地186个服务机构服务于全国10000多家医院WEGO Polymer 威高股份（01066.HK）WEGO Orthepadics 威高骨科（688161.SH）HDCNC 华东数控（002248.SZ）Industry scale产业规模2427 R&D talents/研发人才4 Overseas Expert/海外特聘专家5 Taishan industry leader/泰山产业领军人物114 Academicians of the two

4、 academies start corporation/两院院士建立合作关系5 National scientific research platform/国家级科研平台10 Provincial R&D platform/省级研发平台36 R&D center/研发中心6 Overseas R&D center/海外研发中心1 Second Prize of National Technological Invention/国家技术发明二等奖5 Second Prize in National Science and Technology Progress Award/国家科技进步二等奖1

5、3 Provincial Science and technology progress award/省部级科技进步奖Innovative talents创新人才Innovative platform创新平台Innovative achivement创新成果Establish an internationally leading R&D innovation baseBuild a platform for scientific and technological innovation建立国际领先的研发创新基地，打造科技创新平台2027年，威高通过自主研发、技术引进、对外合作等多种形式，全面布

6、局医疗生态产业，包含生命信息与支持、外科手术、体外诊断、大型影像设备等多个领域，将上市新产品292项，覆盖市场超3000亿元。In 2027,WEGO will launch 292 new products through independent research and development,technology introduction and foreign cooperation,including life information and support,surgical,IVD and imaging equipment,covering a market more than